Pt No. Rituximab Dose Date Administered Other Pv Medications Pre TxPdai Pre TxAbsis Post TxPdai Post TxAbsis Total Tx Days
1 500mg infusion (375mg/m2) 3/03/2014 IVIG 2g/kg, MMF 1gBD, Prednisolone 50mg (weaned to 12.5), Valgancyclovir 450mg BD, azathioprine 100mg ceased (2012-2014) 36 55.65 29 48 112
  500mg infusion (375mg/m2) 17/03/2014            
2 500mg infusion (375mg/m2) 28/11/2012 MMF 1g BD, Prednisolone 75mg 57 122 0 0 674
  500mg infusion (375mg/m2) 12/12/2012            
3* 500mg infusion (375mg/m2) 12/04/2012 Azathioprine (ceased), Prednisolone 3 g/d, MMF 1.5g BD 31 45 0 0 728
  500mg infusion (375mg/m2) 26/04/2012            
  500mg infusion (375mg/m2) 1/09/2013 *Patient qualified for second rituximab treatment course due to recurrence of clinically active disease          
  500mg infusion (375mg/m2) 15/09/2013            
4 500mg infusion (375mg/m2) 30/11/2012 Prednisolone 25mg→4mg/d, MMF 3.5g/d (4x tabs mane, 3 tabs nocte) 80 56 2 2 511
  500mg infusion (375mg/m2) 14/12/2013            
5* 500mg infusion (375mg/m2) 21/09/2012 Azathioprine (contraindicated due to ↑↑ALP and GGT), Prednisolone 25mg/d, MMF 1g BD 84 62.5 7 (due to PIHP ONLY) 0 702
  500mg infusion (375mg/m2) 6/10/2012            
  750mg IV infusion 25/04/2013 *Patient qualified for second rituximab treatment course due to recurrence of clinically active disease          
  750mg IV infusion 10/05/2013            
6 500mg infusion (375mg/m2) 29/09/2011 MMF 500mg BD 10 47 2 1 792
  500mg infusion (375mg/m2) 14/10/2011            
7 500mg infusion (375mg/m2) 13/10/2011 MMF 1g mane, 500mg nocte, Prednisolone. Azathioprine (contraindicated due to lymphopaenia) 47 69 4 2 910
  500mg infusion (375mg/m2) 27/10/2011            
Table 2: Pemphigus Vulgaris Patients managed with Rituximab at the Royal Melbourne Hospital.